NCT01654380View on ClinicalTrials.gov

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy VolunteersDiabetes Mellitus, Type 1
Interventions
DRUG

LY2605541

LY2605541 is a solution. The concentration of LY2605541 is 100 units/milliliter (U/mL).

OTHER

Insulin glargine

Insulin glargine is a 100 U/mL solution in 10 milliliter (mL) glass vial.

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Diego

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01654380 - A Study of LY2605541 Versus Insulin Glargine on Blood Sugar | Biotech Hunter | Biotech Hunter